Serum MicroRNAs as potential biomarkers of primary biliary cirrhosis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Tan, Youwen ^a   Pan, Tengli ^b   Ye, Yun ^a   Ge, Guohong ^a   Chen, Li ^a   Wen, Danfeng ^a   Zou, Shengqiang ^a  

^a The Third People's Hospital of Zhenjiang Affiliated Jiangsu University   (China)

^b Department of Neurology People's Hospital of Bozhou   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; MICRORNA; MICRORNA 122 5P; MICRORNA 1246 L 2R 1; MICRORNA 141 3P; MICRORNA 152 3P; MICRORNA 193A 5P; MICRORNA 194 5P; MICRORNA 200A 3P R 1; MICRORNA 21 3P; MICRORNA 21 5P; MICRORNA 210 3P R 2; MICRORNA 215 5P R 1; MICRORNA 22 3P; MICRORNA 26B 5P; MICRORNA 27B 3P; MICRORNA 320A; MICRORNA 320C R 4; MICRORNA 34A 5P; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY BILIARY CIRRHOSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BILIARY CIRRHOSIS; BLOOD;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MICRORNAS; MIDDLE AGED;

EID: 84908658484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111424     Document Type: Article

References (46)

1. Gershwin ME, Mackay IR, Sturgess A, Coppel RL (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138: 3525-3531.
2. Hirschfield GM, Siminovitch KA (2009) Toward the molecular dissection of primary biliary cirrhosis. Hepatology 50: 1347-1350.
3. Oertelt S, Rieger R, Selmi C., Invernizzi P, Ansari AA, et al. (2007) A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45: 659-665.
4. Lindor KD, Gershwin ME, Poupon R, Kaplan M., Bergasa NV, et al. (2009) Primary biliary cirrhosis. Hepatology 50: 291-308.
5. Corpechot C, Poupon R (2007) Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom. Hepatology 46: 963-965.
6. Gilad S, Meiri E, Yogev Y., Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
7. Giordano S, Columbano A (2013) MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57: 840-847.
8. Bala S, Petrasek J, Mundkur S., Catalano D, Levin I, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946-1957.
9. Blanco-Calvo M, Calvo L, Figueroa A., Haz-Conde M, Anton-Aparicio L, et al. (2012) Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel) 12: 9349-9362.
10. Ge Y, Chen G, Sun L., Liu F (2011) [MicroRNA-29 and fibrosis diseases]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36: 908-912.
11. He Y, Huang C, Zhang S.P., Sun X., Long XR, et al. (2012) The potential of microRNAs in liver fibrosis. Cell Signal 24: 2268-2272.
12. Cermelli S, Ruggieri A, Marrero J.A., Ioannou GN, Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6: e23937.
13. Chen YP, Jin X, Xiang Z., Chen SH, Li YM (2013) Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis. Liver Int 33: 1257-1265.
14. Chen YJ, Zhu JM, Wu H, Fan J., Zhou J, et al. (2013) Circulating microRNAs as a Fingerprint for Liver Cirrhosis. PLoS One 8: e66577.
15. Qin B, Huang F, Liang Y., Yang Z, Zhong R (2013) Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J Gastroenterol Hepatol 28: 543-550.
16. Ninomiya M, Kondo Y, Funayama R., Nagashima T, Kogure T, et al. (2013) Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS One 8: e66086.
17. Pares A (2008) [Natural history of primary biliary cirrhosis]. Gastroenterol Hepatol 31: 500-507.
18. Zhou Q, Li M, Wang X., Li Q, Wang T, et al. (2012) Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci 8: 118-123.
19. Chen C, Ridzon DA, Broomer A.J., Zhou Z., Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
20. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
21. Zhang H, Li QY, Guo Z.Z., Guan Y., Du J, et al. (2012) Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol 18: 5188-5196.
22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
23. Li G, Cai G, Li D., Yin W (2014) MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma. Postgrad Med J 90: 106-112.
24. Li ZJ, Ou-Yang PH, Han XP (2014) Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal 26: 141-148.
25. Marin JJ, Bujanda L, Banales JM (2014) MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol.
26. Papaconstantinou I, Karakatsanis A, Gazouli M., Polymeneas G, Voros D (2012) The role of microRNAs in liver cancer. Eur J Gastroenterol Hepatol 24: 223-228.
27. Mei Q, Li X, Meng Y., Wu Z, Guo M, et al. (2012) A facile and specific assay for quantifying microRNA by an optimized RT-qPCR approach. PLoS One 7: e46890.
28. Steer CJ, Subramanian S (2012) Circulating microRNAs as biomarkers: a new frontier in diagnostics. Liver Transpl 18: 265-269.
29. Smith-Vikos T, Slack FJ (2012) MicroRNAs and their roles in aging. J Cell Sci 125: 7-17.
30. Starkey Lewis PJ, Merz M, Couttet P., Grenet O, Dear J, et al. (2012) Serum microRNA biomarkers for drug-induced liver injury. Clin Pharmacol Ther 92: 291-293.
31. Gougelet A, Colnot S (2013) [microRNA: new diagnostic and therapeutic tools in liver disease?]. Med Sci (Paris) 29: 861-867.
32. Hsu SH, Ghoshal K (2013) MicroRNAs in Liver Health and Disease. Curr Pathobiol Rep 1: 53-62.
33. Bala S, Tilahun Y, Taha O., Alao H, Kodys K, et al. (2012) Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 10: 151.
34. Hu J, Xu Y, Hao J., Wang S, Li C, et al. (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3: 364-371.
35. Wang XW, Heegaard NH, Orum H (2012) MicroRNAs in liver disease. Gastroenterology 142: 1431-1443.
36. Iino I, Kikuchi H, Miyazaki S., Hiramatsu Y, Ohta M, et al. (2013) Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci 104: 624-630.
37. Esau C, Davis S, Murray S.F., Yu XX, Pandey SK, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
38. Lewis AP, Jopling CL (2010) Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans 38: 1553-1557.
39. Zhang Y, Jia Y, Zheng R., Guo Y, Wang Y, et al. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56: 1830-1838.
40. Koutsaki M, Spandidos DA, Zaravinos A (2014) Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett 351: 173-181.
41. Qiu W, Kassem M (2014) miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation. Biochim Biophys Acta 1843: 2114-2121.
42. Yan S, Wang J, Zhang W., Dai J (2013) Circulating MicroRNA Profiles Altered in Mice after 28 Days Exposure to Perfluorooctanoic Acid. Toxicol Lett.
43. Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 47: 737-745.
44. Munoz-Garrido P, Garcia-Fernandez de Barrena M, Hijona E, Carracedo M, Marin JJ, et al. (2012) MicroRNAs in biliary diseases. World J Gastroenterol 18: 6189-6196.
45. Banales JM, Saez E, Uriz M., Sarvide S, Urribarri AD, et al. (2012) Up-regulation of microRNA 506 leads to decreased Cl2/HCO32 anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 56: 687-697.
46. Padgett KA, Lan RY, Leung P.C., Lleo A., Dawson K, et al. (2009) Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 32: 246-253.